HIV testing in national population-based surveys: experience from the Demographic and Health Surveys

Mishra, Vinod; Vaessen, Martin; Boerma, J. Ties; Arnold, Fred; Way, Ann; Barrère, B; Cross, Anne R.; Hong, Rathavuth; Sangha, Jasbir

doi:10.2471/blt.05.029520

Cited by 147 publications

(153 citation statements)

References 9 publications

Supporting

Mentioning

143

Contrasting

Unclassified

Order By: Relevance

“…The study was conducted in the rural Afigya Sekyere district in the Ashanti Region in Ghana (estimated HIV prevalence, !3%) [13]. The area is holoendemic for falciparum malaria, with intense perennial transmission and seasonal peaks.…”

Section: Study Areamentioning

confidence: 99%

A Randomized Controlled Trial of Extended Intermittent Preventive Antimalarial Treatment in Infants

Kobbe¹,

Kreuzberg²,

Adjei

et al. 2007

Clinical Infectious Diseases

View full text Add to dashboard Cite

Background. Intermittent preventive antimalarial treatment in infants (IPTi) with sulfadoxine-pyrimethamine reduces falciparum malaria and anemia but has not been evaluated in areas with intense perennial malaria transmission. It is unknown whether an additional treatment in the second year of life prolongs protection.Methods. A randomized, double-blinded, placebo-controlled trial with administration of sulfadoxine-pyrimethamine therapy at 3, 9, and 15 months of age was conducted with 1070 children in an area in Ghana where malaria is holoendemic. Participants were monitored for 21 months after recruitment through active follow-up visits and passive case detection. The primary end point was malaria incidence, and additional outcome measures were anemia, outpatient visits, hospital admissions, and mortality. Stratified analyses for 6-month periods after each treatment were performed.Results. Protective efficacy against malaria episodes was 20% (95% confidence interval [CI], 11%-29%). The frequency of malaria episodes was reduced after the first 2 sulfadoxine-pyrimethamine applications (protective efficacy, 23% [95% CI, 6%-36%] after the first dose and 17% [95% CI, 1%-30%] after the second dose). After the third treatment at month 15, however, no protection was achieved. Protection against the first or single anemia episode was only significant after the first IPTi dose (protective efficacy, 30%; 95% CI, 5%-49%). The number of anemia episodes increased after the last IPTi dose (protective efficacy, Ϫ24%; 95% CI, Ϫ50% to Ϫ2%).Conclusion. In an area of intense perennial malaria transmission, sulfadoxine-pyrimethamine-based IPTi conferred considerably lower protection than reported in areas where the disease is moderately or seasonally endemic. Protective efficacy is age-dependent, and extension of IPTi into the second year of life does not provide any benefit.

show abstract

Section: Study Areamentioning

confidence: 99%

A Randomized Controlled Trial of Extended Intermittent Preventive Antimalarial Treatment in Infants

Kobbe¹,

Kreuzberg²,

Adjei

et al. 2007

Clinical Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…Recent survey data of circumcised versus uncircumcised males in several African countries show considerable variation in HIV rates. In some African populations, HIV infection rates are lower for circumcised males, while other studies and reports have shown opposite results [8,12,105]. For example, the 2005 survey data for Rwanda show an HIV-infection rate of 3.8% in circumcised men and only 2.7% in uncircumcised men [106].…”

Section: Conflicting Resultsmentioning

confidence: 87%

Male Circumcision is Not the HIV ‘Vaccine’ We Have Been Waiting For!

Green

McAllister

Peterson³

et al. 2008

Future HIV Ther.

View full text Add to dashboard Cite

“…If nonrespondents differ from respondents in their probability of HIV infection, non-response could bias estimates of HIV prevalence. However, Mishra et al (2006), in an analysis of DHS data from eight countries, find that adjusting HIV prevalence estimates for differences in demographic characteristics between respondents and non-respondents does not have much effect on national prevalence estimates using these data. Furthermore, Fortson (2008), using DHS data from Burkina Faso, Cameroon, Ghana, Kenya, and Tanzania, finds no relationship between non-response and reported sexual behavior.…”

Section: Hiv Prevalence Datamentioning

confidence: 99%

HIV, wages, and the skill premium

Marinescu¹

2014

Journal of Health Economics

View full text Add to dashboard Cite

Standard-Nutzungsbedingungen:Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Zwecken und zum Privatgebrauch gespeichert und kopiert werden.Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich machen, vertreiben oder anderweitig nutzen.Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, gelten abweichend von diesen Nutzungsbedingungen die in der dort genannten Lizenz gewährten Nutzungsrechte. www.econstor.eu The Institute for the Study of Labor (IZA) in Bonn is a local and virtual international research center and a place of communication between science, politics and business. IZA is an independent nonprofit organization supported by Deutsche Post Foundation. The center is associated with the University of Bonn and offers a stimulating research environment through its international network, workshops and conferences, data service, project support, research visits and doctoral program. IZA engages in (i) original and internationally competitive research in all fields of labor economics, (ii) development of policy concepts, and (iii) dissemination of research results and concepts to the interested public. Terms of use: Documents in D I S C U S S I O N P A P E R S E R I E SIZA Discussion Papers often represent preliminary work and are circulated to encourage discussion. Citation of such a paper should account for its provisional character. A revised version may be available directly from the author.

show abstract

HIV testing in national population-based surveys: experience from the Demographic and Health Surveys

Cited by 147 publications

References 9 publications

A Randomized Controlled Trial of Extended Intermittent Preventive Antimalarial Treatment in Infants

A Randomized Controlled Trial of Extended Intermittent Preventive Antimalarial Treatment in Infants

Male Circumcision is Not the HIV ‘Vaccine’ We Have Been Waiting For!

HIV, wages, and the skill premium

Contact Info

Product

Resources

About